NEAD: Novel Training Environment to Normalize Altered Finger Force Direction Post Stroke

Sponsor
VA Office of Research and Development (U.S. Fed)
Overall Status
Recruiting
CT.gov ID
NCT03995069
Collaborator
(none)
60
1
2
36.1
1.7

Study Details

Study Description

Brief Summary

Despite the functional importance, fingertip forces are rarely explicitly addressed with feedback in therapy. This gap in treatment is due to a lack of tools to provide explicit feedback on patients' volitional finger force generation. To address this unmet need, the investigators developed a novel tool for practice of volitional three-dimensional (3D) force generation with explicit feedback. The objective of this project is to determine if 3D finger force training is an effective tool in restoring hand function post stroke.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: 3D
  • Behavioral: 1D
N/A

Detailed Description

Despite the functional importance, fingertip forces are rarely explicitly addressed with feedback in therapy. This gap in treatment is due to a lack of tools to provide explicit feedback on patients' volitional finger force generation. To address this unmet need, the investigators developed a novel tool for practice of volitional three-dimensional (3D) force generation with explicit feedback. The objective of this project is to determine if 3D finger force training is an effective tool in restoring hand function post stroke.

Stroke survivors with moderate to severe hand impairment with at least palpable volitional grip force will randomly be assigned to either the experimental or control group, stratified by impairment level. Both groups will undergo 3 1-hr training sessions per week for 6 weeks in which they practice volitional finger force generation against force sensors. The experimental group will practice for various target force directions to explore the 3D force workspace and receive feedback in 3D force, while the control group will practice 1D force generation without feedback on other directional forces on a computer screen.

Training will progress by increasing influence of flexion synergy by varying posture requirements and increasing force level, introducing feedback delay, and incorporating unilateral/bilateral activity. Evaluation will occur at baseline (3 times over 3 weeks to establish baseline trends) and every 2 weeks during 6-week intervention to determine pattern of progress, and at 1-month follow-up to assess retention.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Novel Training Environment to Normalize Altered Finger Force Direction Post Stroke
Actual Study Start Date :
Oct 28, 2020
Anticipated Primary Completion Date :
Oct 31, 2023
Anticipated Study Completion Date :
Oct 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: 3D

The participant's voluntary grip forces in all 3 dimensions will be shown to the participant via computer screen.

Behavioral: 3D
Practice generating grip force to the target shown on the computer screen in 3 dimensions.

Active Comparator: 1D

The participant's voluntary grip force in 1 dimension will be shown to the participant via computer screen.

Behavioral: 1D
Practice generating grip force to the target shown on the computer screen in 1 dimension.

Outcome Measures

Primary Outcome Measures

  1. Action Research Arm Test (ARAT) [3rd baseline to within 1 week post intervention]

    a clinical assessment for upper extremity function

Other Outcome Measures

  1. Box and Block Test [3rd baseline to within 1 week post intervention]

    a clinical assessment for upper extremity function.

  2. Force Direction [3rd baseline to within 1 week post intervention]

    Angular deviation of the grip force vector from the target direction

  3. Action Research Arm Test [3rd baseline to 1 month post intervention]

    a clinical assessment for upper extremity function

  4. Box and Block Test [3rd baseline to 1 month post intervention]

    a clinical assessment for upper extremity function.

  5. Force Direction [baseline to 1 month post intervention]

    Angular deviation of the grip force vector from the target direction

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Survived a stroke at least 3 months ago

  • Moderate to severe hand impairment (Chedoke-McMaster Hand Stage 2-4)

  • Ability to generate palpable volitional grip force upon cue

  • Sufficient cognitive ability to participate (NIH Stroke Scale, NIHSS, Questions and Commands score = 0-1)

  • Ability to recognize all quadrants of the visual field (NIHSS Visual Field Test score = 0)

Exclusion Criteria:
  • Concurrent upper limb rehabilitation

  • Inability to follow 2-step commands

  • Severe muscle tone prohibiting passive movement of the fingers or proper placement of the fingers on the force sensors as needed to participate in the training (Modified Ashworth Scale=4-5 out of 5)

  • Change in spasticity medication or botulinum toxin injection in the upper limb within 3 months prior to or during enrollment

  • Total sensory loss on fingertips (NIHSS Sensory score=2)

  • Comorbidity (e.g., orthopaedic conditions that limit ranges of motion, premorbid neurologic conditions)

  • Language barrier or cognitive impairment that precludes providing consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ralph H. Johnson VA Medical Center, Charleston, SC Charleston South Carolina United States 29401-5799

Sponsors and Collaborators

  • VA Office of Research and Development

Investigators

  • Principal Investigator: Na Jin Seo, PhD MS BS, Ralph H. Johnson VA Medical Center, Charleston, SC

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
VA Office of Research and Development
ClinicalTrials.gov Identifier:
NCT03995069
Other Study ID Numbers:
  • A3066-R
  • NCT03993756
First Posted:
Jun 21, 2019
Last Update Posted:
Feb 16, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by VA Office of Research and Development
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 16, 2022